/
DNA
$7.24+$0.03 (+0.42%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$485.5M
67M shares
52-week range
$5.37 – $17.58
15% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NYSE
CS
Change$-479.96
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
www.ginkgobioworks.com- Employees
- 485
- IPO / List date
- Apr 19, 2021
- HQ
- BOSTON, MA
Held by traders on TradeandTell
No one on the platform currently holds DNA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 100,456 | $615.8K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-08-20 | 1-for-40reverse |
Recent trades on TradeandTell
No one on the platform has traded DNA yet.
